
Jason Michael Nolan
Examiner (ID: 10620)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623 |
| Total Applications | 703 |
| Issued Applications | 439 |
| Pending Applications | 98 |
| Abandoned Applications | 189 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5509215
[patent_doc_number] => 20090082422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DEUTERIUM-ENRICHED LEVETIRACETAM'
[patent_app_type] => utility
[patent_app_number] => 12/233651
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082422.pdf
[firstpage_image] =>[orig_patent_app_number] => 12233651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/233651 | DEUTERIUM-ENRICHED LEVETIRACETAM | Sep 18, 2008 | Abandoned |
Array
(
[id] => 5509213
[patent_doc_number] => 20090082420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DEUTERIUM-ENRICHED VILDAGLIPTIN'
[patent_app_type] => utility
[patent_app_number] => 12/233322
[patent_app_country] => US
[patent_app_date] => 2008-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3292
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082420.pdf
[firstpage_image] =>[orig_patent_app_number] => 12233322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/233322 | DEUTERIUM-ENRICHED VILDAGLIPTIN | Sep 17, 2008 | Abandoned |
Array
(
[id] => 5310902
[patent_doc_number] => 20090018183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 12/232399
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5900
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12232399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/232399 | N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands | Sep 16, 2008 | Abandoned |
Array
(
[id] => 5429125
[patent_doc_number] => 20090088435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHODS AND COMPOUNDS FOR TREATING RETINOL-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/210802
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 41346
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088435.pdf
[firstpage_image] =>[orig_patent_app_number] => 12210802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/210802 | Methods and compounds for treating retinol-related diseases | Sep 14, 2008 | Issued |
Array
(
[id] => 8846481
[patent_doc_number] => 08455663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Halosubstituted aryloxyalkylimidazolines for use as pesticides'
[patent_app_type] => utility
[patent_app_number] => 12/677825
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12677825
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677825 | Halosubstituted aryloxyalkylimidazolines for use as pesticides | Sep 8, 2008 | Issued |
Array
(
[id] => 5272348
[patent_doc_number] => 20090076124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ROPINIROLE'
[patent_app_type] => utility
[patent_app_number] => 12/206307
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206307 | DEUTERIUM-ENRICHED ROPINIROLE | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5272345
[patent_doc_number] => 20090076121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED SUMATRIPTAN'
[patent_app_type] => utility
[patent_app_number] => 12/206417
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206417 | DEUTERIUM-ENRICHED SUMATRIPTAN | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5272507
[patent_doc_number] => 20090076283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Method of crystallizing carvedilol phosphate and the product thereof'
[patent_app_type] => utility
[patent_app_number] => 12/231760
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 307
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076283.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231760 | Method of crystallizing carvedilol phosphate and the product thereof | Sep 4, 2008 | Abandoned |
Array
(
[id] => 239615
[patent_doc_number] => 07592332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/201766
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19489
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201766 | Cytokine inhibitors | Aug 28, 2008 | Issued |
Array
(
[id] => 8375383
[patent_doc_number] => 08258176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Dithiolopyrrolone compounds, the preparation and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/676470
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12346
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676470 | Dithiolopyrrolone compounds, the preparation and the use thereof | Aug 28, 2008 | Issued |
Array
(
[id] => 5324335
[patent_doc_number] => 20090062325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED TIOTROPIUM'
[patent_app_type] => utility
[patent_app_number] => 12/195907
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062325.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195907 | DEUTERIUM-ENRICHED TIOTROPIUM | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5586278
[patent_doc_number] => 20090105480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/193788
[patent_app_country] => US
[patent_app_date] => 2008-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9485
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105480.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193788 | PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR | Aug 18, 2008 | Abandoned |
Array
(
[id] => 4759959
[patent_doc_number] => 20080312185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 12/191561
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25460
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12191561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/191561 | SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES | Aug 13, 2008 | Abandoned |
Array
(
[id] => 5310859
[patent_doc_number] => 20090018140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 12/183580
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20889
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12183580
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/183580 | Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters | Jul 30, 2008 | Issued |
Array
(
[id] => 123232
[patent_doc_number] => 07705030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation'
[patent_app_type] => utility
[patent_app_number] => 12/180795
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45228
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705030.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180795 | Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation | Jul 27, 2008 | Issued |
Array
(
[id] => 4948937
[patent_doc_number] => 20080305063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => '1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances'
[patent_app_type] => utility
[patent_app_number] => 12/175221
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19404
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305063.pdf
[firstpage_image] =>[orig_patent_app_number] => 12175221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/175221 | 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances | Jul 16, 2008 | Issued |
Array
(
[id] => 4949937
[patent_doc_number] => 20080306063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/171844
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71798
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306063.pdf
[firstpage_image] =>[orig_patent_app_number] => 12171844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/171844 | Phenylamino isothiazole carboxamidines as MEK inhibitors | Jul 10, 2008 | Issued |
Array
(
[id] => 6296455
[patent_doc_number] => 20100240656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'COMPOUNDS AS HSP90 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/668170
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 36690
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240656.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668170 | COMPOUNDS AS HSP90 INHIBITORS | Jul 8, 2008 | Abandoned |
Array
(
[id] => 5350216
[patent_doc_number] => 20090005577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Method of producing 1-substituted 3-pyrrolates'
[patent_app_type] => utility
[patent_app_number] => 12/215569
[patent_app_country] => US
[patent_app_date] => 2008-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4232
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005577.pdf
[firstpage_image] =>[orig_patent_app_number] => 12215569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/215569 | Method of producing 1-substituted 3-pyrrolates | Jun 27, 2008 | Abandoned |
Array
(
[id] => 6511977
[patent_doc_number] => 20100210853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'PROCESS FOR PREPARATION OF CANDESARTAN CILEXETIL'
[patent_app_type] => utility
[patent_app_number] => 12/678316
[patent_app_country] => US
[patent_app_date] => 2008-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2497
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210853.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678316
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678316 | PROCESS FOR PREPARATION OF CANDESARTAN CILEXETIL | Jun 23, 2008 | Abandoned |